CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate the release of growth hormone (GH) from the pituitary gland. It is known for its ability to promote the secretion of endogenous GH, leading to increased protein synthesis, muscle growth, fat loss, and improved recovery and immune function. CJC-1295 has a longer half-life than other GHRH analogs due to its ability to bind to albumin, extending its effects and making it more efficient for therapeutic use. It is commonly researched in the context of anti-aging, muscle wasting diseases, and metabolic conditions.